November 27, 2015
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
November 27, 2015
No revenues for Kiadis Pharma in the first 9 months 2015
Kiadis Pharma did not generate any revenues in the first nine months of 2015, the company said Friday.
November 27, 2015
(Edited) RPG Life Science calms down investors. Says media writings are premature
RPG Life Science Limited has said that the media reports which said that “RPG Life Plans Skincare Foray, May Roll Out Biz Next Month” came out premature.
November 26, 2015
GSK in China – escaping the shadow of a scandal
GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014.
November 26, 2015
Sinclair IS Pharma going aesthetic
Sinclair IS Pharma plc will sell its non-aesthetics business to Alliance Pharma plc for £132m
November 26, 2015
LEO Pharma appoints Svend Andersen EVP head of Europe+
LEO Pharma has named Svend Andersen as incoming EVP, Head of Region EUROPE+, who will assume the position of Executive Vice President, Head of Region EUROPE+, on January 1, 2016. He will join LEO Pharma’s Executive Leadership Team and report directly to the CEO.
November 26, 2015
Teva to receive global development and commercial rights to Hemtares’ novel CGRP antagonists
Teva will receive exclusive global rights to develop, manufacture and commercialize novel, small-molecule calcitonin gene-related peptide (CGRP) antagonists discovered by Sosei Group’s subsidiary Heptares, for the treatment of migraine.
November 25, 2015
Allergan settles with New York over Memantine. Agrees to pay $170K for state’s litigation expenses
Allergan has agreed with the New York State Attorney General’s Office to end the litigation under Section 2 of the Sherman Act, and other statutes with the Attorney General over the decision of Forest Laboratories
November 25, 2015
U.S. politicians slam tax-avoiding Pfizer-Allergan deal
U.S. politicians condemned Pfizer Inc’s deal with Allergan Plc as a tax dodge on Monday, bringing another round of hand-wringing in Washington over the corporate tax code, though legislative action before 2017 is unlikely.
November 24, 2015
Presage appoints two new directors
Presage Biosciences, an oncology company has appointed Tachi Yamada and Christoph Lengauer to its board of directors.